BioArctic AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOA-B.ST research report →
Companywww.bioarctic.se
BioArctic AB (publ), a research-intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops BAN2401, an immunotherapy, which is in Phase III clinical trials targeting the toxic amyloid-beta oligomers/protofibrils in Alzheimer's disease; and is in preclinical trials for treating Down's syndrome with dementia and traumatic brain injury, as well as BAN2401 Back-up, a disease modifying antibody treatment that is in late preclinical Phase for patients with early Alzheimer's disease. It also develops ABBV-0805, a monoclonal antibody for treating Parkinson's disease; and SC0806, a biodegradable device that is in Phase I/II clinical trial for spinal cord injuries.
- CEO
- Gunilla Osswald
- IPO
- 2017
- Employees
- 107
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $28.16B
- P/E
- 132.19
- P/S
- 24.55
- P/B
- 12.82
- EV/EBITDA
- 62.52
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 94.13%
- Op Margin
- 34.50%
- Net Margin
- 18.59%
- ROE
- 10.44%
- ROIC
- 8.88%
Growth & Income
- Revenue
- $2.00B · 676.80%
- Net Income
- $1.02B · 677.33%
- EPS
- $11.55 · 677.50%
- Op Income
- $1.37B
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $364.40
- 52W Low
- $172.90
- 50D MA
- $320.99
- 200D MA
- $305.72
- Beta
- -0.78
- Avg Volume
- 195.65K
Get TickerSpark's AI analysis on BIOA-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIOA-B.ST Coverage
We haven't published any research on BIOA-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIOA-B.ST Report →